subscribeSubscribe
US FDA approves French drugmaker Ipsen`s rare bone disorder drug

US FDA approves French drugmaker Ipsen`s rare bone disorder drug
REUTERS
17 Aug 2023
Share Share
Ipsen says EC rejects marketing authorization for bone disorder drug

Ipsen says EC rejects marketing authorization for bone disorder drug
REUTERS
19 Jul 2023
Share Share
FDA adcomm votes in favor of Ipsen`s fibrodysplasia drug

FDA adcomm votes in favor of Ipsen`s fibrodysplasia drug
Katherine Lewin ENDPTS
29 Jun 2023
Share Share
Ipsen announces +ve outcome of FDA Advisory Committee on investig. palovarotene

Ipsen announces +ve outcome of FDA Advisory Committee on investig. palovarotene
GLOBENEWSWIRE
28 Jun 2023
Share Share
FDA reviewers on Ipsen`s potential ultra-rare disease drug

FDA reviewers on Ipsen`s potential ultra-rare disease drug
Zachary Brennan ENDPTS
27 Jun 2023
Share Share
Ipsen receives CHMP negative opinion, following re-examination of FOP treatment

Ipsen receives CHMP negative opinion, following re-examination of FOP treatment
GLOBENEWSWIRE
26 May 2023
Share Share
Ipsen’s rare disease drug palovarotene knocked back in EU

Ipsen’s rare disease drug palovarotene knocked back in EU
BUSINESSWIRE
28 Jan 2023
Share Share
Ipsen receives Complete Response Letter for palovarotene

Ipsen receives Complete Response Letter for palovarotene
PRESS RELEASE
24 Dec 2022
Share Share
Ipsen faces yet another delay for rare disease drug in US

Ipsen faces yet another delay for rare disease drug in US
Phil Taylor PHARMAPHORUM
26 Oct 2022
Share Share
FDA plans Halloween adcomm for Ipsen’s second chance at rare disease drug

FDA plans Halloween adcomm for Ipsen’s second chance at rare disease drug
Max Gelman ENDPTS
22 Aug 2022
Share Share